Elfiky, A. A. (2020). Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]. Life Sci.
Chicago Style aipamenaElfiky, Abdo A. "Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA Dependent RNA Polymerase (RdRp): A Molecular Docking Study” [Life Sci. 253 (2020) 117592]." Life Sci 2020.
MLA aipamenaElfiky, Abdo A. "Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA Dependent RNA Polymerase (RdRp): A Molecular Docking Study” [Life Sci. 253 (2020) 117592]." Life Sci 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.